read more

first_imgFor more information: www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/Reports/ucm383672.htm FacebookTwitterLinkedInPrint分享 Technology | Artificial Intelligence | July 18, 2019 Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded… read more News | Breast Imaging | August 02, 2019 Volpara to Distribute Screenpoint Medical’s Transpara AI Solution Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint’s Transpara… read more Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev AI Models Predict Breast Cancer With Radiologist-level Accuracy Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer… read more News | Mammography Reporting Software | July 26, 2019 Ikonopedia Releases Automated Combined Reporting Package at AHRA Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured… read more Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire. News | PACS | August 09, 2019 Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and… read more Image courtesy of Imago Systems News | Artificial Intelligence | August 13, 2019 Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that… read more The FDA said the facility has ceased performing mammography. Technology | Breast Biopsy Systems | July 24, 2019 Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its… read more Feature | January 30, 2014 ACR Takes Action Against Georgia Mammography Facility The Mountain Lakes Medical Center in Clayton, Ga., was investigated in April 2013 by the State of Georgia, under contract to the U.S. Food and Drug Administration (FDA). An annual Mammography Quality Standards Act (MQSA) inspection revealed the facility operated for 75 days without performing film processor quality control when clinical images were processed.  On May 13, 2013, FDA required the facility submit images to the ACR for an additional mammography review (AMR). On June 20, 2013, the ACR notified the facility that the deficiencies found in the evaluated mammograms posed a serious risk to human health.  As a result, the ACR revoked the facility’s accreditation effective June 28, 2013.  Technology | Mammography Reporting Software | July 25, 2019 Hologic Partners With MagView to Develop Unifi EQUIP Solution Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an… read more News | Ultrasound Women’s Health | July 11, 2019 FDA Clears Koios DS Breast 2.0 AI-based Software Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA). Related Content IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology. News | Mammography | August 14, 2019 Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year… read more January 30, 2013 — A mammography facility in Georgia had its mammography acceditation revoked by the  American College of Radiology (ACR) following an investigation that showed major quality issues.  Based on the serious image quality deficiencies noted during the AMR, the FDA required the facility perform a patient and referring healthcare provider notification (PPN) to alert all at-risk patients (and their providers) of the mammography image quality problems at the facility. On Jan. 24, 2014, the FDA notified the facility that it successfully completed the PPN process. read morelast_img

Post A Comment

Your email address will not be published. Required fields are marked *